Thank you for Subscribing to Cannabis Business Insights Weekly Brief
Cannabis Business Insights: Specials Magazine
Clever Leaves International Inc. (OTC: CLVR)
Building Consistency in Medical Cannabis Production
Medical cannabis production requires more than effective cultivation. Suppliers serving pharmaceutical manufacturers and regulated markets must deliver consistent products, meet stringent quality standards and comply with regulations governing cannabinoid production and distribution. Maintaining these requirements depends on control over each stage of production, from growing and processing cannabis to preparing materials for commercial use. Clever Leaves International Inc. (OTC: CLVR) brings these stages together through an integrated production model focused on pharmaceutical-grade cannabinoids. Its cultivation and extraction operations in Colombia support a portfolio spanning cannabis flower, extracts, active pharmaceutical ingredients and finished formulations. By connecting cultivation with processing, product development and regulatory expertise, Clever Leaves supplies business customers with products tailored to the needs of regulated markets.
Cannabis Insurance Brokerage
Cannasure | One80 Intermediaries
Specialization Built for Cannabis
Jim McErlean, Business Development Manager
In cannabis, risk rarely stays where it starts. A loss at one stage can create exposures across cultivation, processing, manufacturing, distribution and retail, particularly for vertically integrated businesses. Cannasure, a cannabis-focused insurance business operated by One80 Intermediaries, develops specialized insurance solutions for these connected risks. For more than 15 years, the company has evolved its insurance solutions alongside changes in cannabis operations, regulations and insurance requirements. Cannasure’s underwriters evaluate the entire operation, from cultivation through retail, to see how those risks interact. They identify where losses can occur, which liabilities may follow and how the impact can move downstream, then assess whether the insurance structure responds across the business. That understanding shapes Cannasure’s proprietary Cannabis and Hemp Package Program. Designed around cannabis-specific exposures, the program addresses living plant material, goods in process, completed stock, equipment, business income and products liability, all areas that conventional commercial insurance structures may not fully address.
Cannabis Solutions
For cannabis cultivators, finding genetics that perform reliably at a commercial scale and give products a distinct identity can be difficult. Proven cultivars offer consistency but little differentiation. To explore new genetics, operators must commit canopy, labor and capital to plants that may never reach production. ALTVM absorbs that uncertainty of genetic discovery. It has spent over seven years building an operator-driven genetics R&D platform to identify rare cultivars that combine consumer appeal with the performance required by operators. At scale, access to elite genetics that deliver strong yields and consistent laboratory results can make or break operating margins, potentially translating into six- or seven-figure differences in annual profitability. Selections advance through repeated flowering, production, laboratory and retail evaluation, building knowledge around each cultivar. This helps cultivators create more sellable value from licensed growing space, while brands gain proprietary cultivars competitors cannot immediately reproduce. Genetics consulting and phenotype selection further help assess brand fit and commercial performance. “Our long-term goal is to become the brand behind the brands through elite genetics and scalable selection systems that give operators a unique competitive advantage,” says David Dodson, owner and founder.
Cannabis Retailing
Building Authentic Cannabis Brands
Rachel Block, Marketing Director, NOBO
Vertically-Integrated Cannabis
Manufacturing at Scale: Leadership Lessons From Cannabis Production
Danny Malafouris, Director of Production, Deep Roots Harvest
Cannabis Manufacturing
Scaling Scientific Operations Through Hands-on Leadership
Glenn Swanson, Director Laboratory Operations, Resinate
Cannabis Manufacturing
The Operating Discipline Behind Credible hemp Manufacturing
Dr. Sierra Solnick, Production Director, THE HEMP COLLECT
Cannabis Lighting
Building Trust and Brand Value In Cannabis
Nikole K., Director of Wholesale & Marketing, BRIX CANNABIS
Organic CBD Oil
Shaping the Future of Functional Foods
Snehdeep Brar, VP Research and Development | Commercialization, LT Foods
Medical Cannabis
More than Milligrams: What the Cannabis Industry Still Gets Wrong About Patient Care
Jennifer McGuire, RN, MSN, Chief Executive Officer and Co-Founder, CAMP Cannabis
IN MY OPINION
Cannabis Marketing
Consumers Don't Buy Categories. They Buy Occasions
Pete Macfarlane,Chief Marketing Officer, Earl Giles
LAST WORD
Medical Cannabis
The Future of Cannabis Genetics Starts With True Breeding
Andy Wright, Director of Operations, Atlas Seed
IN FOCUS
Cannabis Insurance Services for Smarter Business Risk Management
Specialized cannabis insurance helps businesses manage operational risks, protect assets, support continuity, and strengthen long-term financial planning.
Advanced Cannabis Cultivation Solutions Transforming Canada's Market
Cannabis cultivation solutions improve efficiency, ensure compliance, optimize resources, and enable sustainable, scalable production for long-term industry growth and competitiveness.
EDITORIAL
Building a More Mature Cannabis Industry
Cannabis is becoming a more sophisticated business, but its next stage of growth will depend on more than cultivation capacity or market access. Operators must differentiate their products, manage interconnected risks, earn consumer trust and, in medical markets, put patient needs at the center of the experience. This edition of Cannabis Business Insights explores how companies and leaders are addressing these demands.
Leading the issue is Clever Leaves International Inc. (OTC: CLVR), named the Top Medical Cannabis Production Company 2026. The company has cultivation and extraction facilities in Colombia, where it combines efficient production processes with pharmaceutical-quality standards, as well as regulatory experience and a supply chain that caters to corporate clients all over the world. The use of natural light and rainfall further illustrates this point.
The featured profiles consider two more fundamental aspects of growth within the industry. Cannasure | One80 Intermediaries, which is Top Cannabis Insurance Services 2026, tackles risk assessment using Cannasure, a cannabis-specific insurance company. ALTVM, recognized as Top Cannabis Cultivation Solutions 2026, deals with the genetic aspect of commercial success. Staged phenotype selection and repeated cultivation, laboratory and retail tests help find a cultivar that combines uniqueness with consistency and popularity.
The issue’s CXO contributors bring the discussion closer to the people who shape the market. Nikole K., Director of Wholesale & Marketing at BRIX CANNABIS, reflects on authentic branding, trusted partnerships and the importance of quality and consumer education in building lasting loyalty. Jennifer McGuire, RN, MSN, CEO and CoFounder of CAMP Cannabis, challenges the industry’s fixation on THC potency, arguing for more clinically informed guidance, responsible product recommendations and a stronger patient-centered approach to medical cannabis.
Together, these perspectives reveal an industry moving toward greater specialization and accountability. Explore this edition to discover how cultivation science, risk expertise, credible branding and patientfocused leadership are helping shape its next chapter.
